Search

Your search keyword '"Trines, Serge A."' showing total 225 results
Start Over Author "Trines, Serge A."
225 results on '"Trines, Serge A."'

2. Very High-Power Ablation for Contiguous Pulmonary Vein Isolation: Results From the Randomized POWER PLUS Trial

Author

O’Neill, Louisa, El Haddad, Milad, Berte, Benjamin, Kobza, Richard, Hilfiker, Gabriela, Scherr, Daniel, Manninger, Martin, Wijnmaalen, Adrianus P., Trines, Serge A., Wielandts, Jean-Yves, Gillis, Kris, Lycke, Michelle, De Becker, Benjamin, Tavernier, Rene, Le Polain De Waroux, Jean-Benoit, Knecht, Sebastien, and Duytschaever, Mattias

Published
2023
Full Text
View/download PDF

8. ‘Trapped re-entry’ as source of acute focal atrial arrhythmias

Author

De Coster, Tim, primary, Teplenin, Alexander S, additional, Feola, Iolanda, additional, Bart, Cindy I, additional, Ramkisoensing, Arti A, additional, den Ouden, Bram L, additional, Ypey, Dirk L, additional, Trines, Serge A, additional, Panfilov, Alexander V, additional, Zeppenfeld, Katja, additional, de Vries, Antoine A F, additional, and Pijnappels, Daniël A, additional

Published
2023
Full Text
View/download PDF

9. Incidence and Clinical Significance of Cerebral Embolism During Atrial Fibrillation Ablation With Duty-Cycled Phased-Radiofrequency Versus Cooled-Radiofrequency: A Randomized Controlled Trial

Author

Keçe, Fehmi, Bruggemans, Eline F., de Riva, Marta, Alizadeh Dehnavi, Reza, Wijnmaalen, Adrianus P., Meulman, Tamara J., Brugman, Julia A., Rooijmans, Anouk M., van Buchem, Mark A., Middelkoop, Huub A., Eikenboom, Jeroen, Schalij, Martin J., Zeppenfeld, Katja, and Trines, Serge A.

Published
2019
Full Text
View/download PDF

11. Use of Smart Technology for the Early Diagnosis of Complications After Cardiac Surgery: The Box 2.0 Study Protocol

Author

Biersteker, Tom E, Boogers, Mark J, de Lind van Wijngaarden, Robert AF, Groenwold, Rolf HH, Trines, Serge A, van Alem, Anouk P, Kirchhof, Charles JHJ, van Hof, Nicolette, Klautz, Robert JM, Schalij, Martin J, and Treskes, Roderick W

Subjects
Medicine, Computer applications to medicine. Medical informatics, R858-859.7
Abstract

BackgroundAtrial fibrillation (AF), sternal wound infection, and cardiac decompensation are complications that can occur after cardiac surgery. Early detection of these complications is clinically relevant, as early treatment is associated with better clinical outcomes. Remote monitoring with the use of a smartphone (mobile health [mHealth]) might improve the early detection of complications after cardiac surgery. ObjectiveThe primary aim of this study is to compare the detection rate of AF diagnosed with an mHealth solution to the detection rate of AF diagnosed with standard care. Secondary objectives include detection of sternal wound infection and cardiac decompensation, as well as assessment of quality of life, patient satisfaction, and cost-effectiveness. MethodsThe Box 2.0 is a study with a prospective intervention group and a historical control group for comparison. Patients undergoing cardiac surgery at Leiden University Medical Center are eligible for enrollment. In this study, 365 historical patients will be used as controls and 365 other participants will be asked to receive either The Box 2.0 intervention consisting of seven home measurement devices along with a video consultation 2 weeks after discharge or standard cardiac care for 3 months. Patient information will be analyzed according to the intention-to-treat principle. The Box 2.0 devices include a blood pressure monitor, thermometer, weight scale, step count watch, single-lead electrocardiogram (ECG) device, 12-lead ECG device, and pulse oximeter. ResultsThe study started in November 2018. The primary outcome of this study is the detection rate of AF in both groups. Quality of life is measured with the five-level EuroQol five-dimension (EQ-5D-5L) questionnaire. Cost-effectiveness is calculated from a society perspective using prices from Dutch costing guidelines and quality of life data from the study. In the historical cohort, 93.9% (336/358) completed the EQ-5D-5L and patient satisfaction questionnaires 3 months after cardiac surgery. ConclusionsThe rationale and design of a study to investigate mHealth devices in postoperative cardiac surgery patients are presented. The first results are expected in September 2020. Trial RegistrationClinicalTrials.gov NCT03690492; http://clinicaltrials.gov/show/NCT03690492 International Registered Report Identifier (IRRID)DERR1-10.2196/16326

Published
2020
Full Text
View/download PDF

12. 'Trapped re-entry' as source of acute focal atrial arrhythmias.

Author

Coster, Tim De, Teplenin, Alexander S, Feola, Iolanda, Bart, Cindy I, Ramkisoensing, Arti A, Ouden, Bram L den, Ypey, Dirk L, Trines, Serge A, Panfilov, Alexander V, Zeppenfeld, Katja, Vries, Antoine A F de, and Pijnappels, Daniël A

Subjects
ATRIAL arrhythmias, ATRIAL fibrillation, ATRIUMS (Architecture), ION channels, ARRHYTHMIA
Abstract

Aims Diseased atria are characterized by functional and structural heterogeneities, adding to abnormal impulse generation and propagation. These heterogeneities are thought to lie at the origin of fractionated electrograms recorded during sinus rhythm (SR) in atrial fibrillation (AF) patients and are assumed to be involved in the onset and perpetuation (e.g. by re-entry) of this disorder. The underlying mechanisms, however, remain incompletely understood. Here, we tested whether regions of dense fibrosis could create an electrically isolated conduction pathway (EICP) in which re-entry could be established via ectopy and local block to become 'trapped'. We also investigated whether this could generate local fractionated electrograms and whether the re-entrant wave could 'escape' and cause a global tachyarrhythmia due to dynamic changes at a connecting isthmus. Methods and results To precisely control and explore the geometrical properties of EICPs, we used light-gated depolarizing ion channels and patterned illumination for creating specific non-conducting regions in silico and in vitro. Insight from these studies was used for complementary investigations in virtual human atria with localized fibrosis. We demonstrated that a re-entrant tachyarrhythmia can exist locally within an EICP with SR prevailing in the surrounding tissue and identified conditions under which re-entry could escape from the EICP, thereby converting a local latent arrhythmic source into an active driver with global impact on the heart. In a realistic three-dimensional model of human atria, unipolar epicardial pseudo-electrograms showed fractionation at the site of 'trapped re-entry' in coexistence with regular SR electrograms elsewhere in the atria. Upon escape of the re-entrant wave, acute arrhythmia onset was observed. Conclusions Trapped re-entry as a latent source of arrhythmogenesis can explain the sudden onset of focal arrhythmias, which are able to transgress into AF. Our study might help to improve the effectiveness of ablation of aberrant cardiac electrical signals in clinical practice. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Pleomorphic Ventricular Tachycardia in Dilated Cardiomyopathy Predicts Ventricular Tachycardia Recurrence After Ablation Independent From Cardiac Function: Comparison With Patients With Ischemic Heart Disease

Author

Kimura, Yoshitaka, primary, de Riva, Marta, additional, Ebert, Micaela, additional, Glashan, Claire, additional, Wijnmaalen, Adrianus P., additional, Piers, Sebastiaan R., additional, Dekkers, Olaf M., additional, Trines, Serge A., additional, and Zeppenfeld, Katja, additional

Published
2023
Full Text
View/download PDF

15. Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation

Author

van der Endt, Vera H W, primary, Milders, Jet, additional, Penning de Vries, Bas B L, additional, Trines, Serge A, additional, Groenwold, Rolf H H, additional, Dekkers, Olaf M, additional, Trevisan, Marco, additional, Carrero, Juan J, additional, van Diepen, Merel, additional, Dekker, Friedo W, additional, and de Jong, Ype, additional

Published
2022
Full Text
View/download PDF

19. The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association

Author

Arbelo, Elena, Brugada, Josep, Hindricks, Gerhard, Maggioni, Aldo P., Tavazzi, Luigi, Vardas, Panos, Laroche, Cécile, Anselme, Frédéric, Inama, Giuseppe, Jais, Pierre, Kalarus, Zbigniew, Kautzner, Josef, Lewalter, Thorsten, Mairesse, Georges H., Perez-Villacastin, Julian, Riahi, Sam, Taborsky, Milos, Theodorakis, George, Trines, Serge A., Brugada, Josep, Arbelo, Elena, Hindriks, Gerhard, Maggioni, Aldo P., Morgan, John, Tavazzi, Luigi, Vardas, Panos, Alonso, Angeles, Ferrari, Roberto, Komajda, Michel, Tavazzi, Luigi, Wood, David, Vardas, Panos, Brugada, Josep, Mairesse, Georges, Taborsky, Milos, Kautzner, Josef, Lewalter, Thorsten, Riahi, Sam, Jais, Pierre, Anselme, Frédéric, Theodorakis, George, Inama, Giuseppe, Trines, Serge, Kalarus, Zbigniew, Villacastin, Julian Perez, Maggioni, Aldo P., Manini, Malika, Gracia, Gérard, Laroche, Cécile, Missiamenou, Viviane, Taylor, Charles, Konte, Marème, Fiorucci, Emanuela, Lefrancq, Elin Folkesson, Glémot, Myriam, McNeill, Patti-Ann, Bois, Timothée, Heidbüchel, H., Nuyens, D., Boland, J., Dinraths, V., Herzet, J.-M., Hoffer, E., Malmendier, D., Massoz, M., Pourbaix, S., Ballant, E., Blommaert, D., Deceuninck, O., Dormal, F., Xhaet, O., De Potter, T., Geelen, P., Derycker, K., Duytschaever, M., Tavernier, R., Vandekerckhove, Y., Vankats, D., Bulava, A., Hanis, J., Sitek, D., Blahova, M., Cihak, R., Hanyasova, L., Jansova, H., Peichl, P., Tanzerova, M., Wichterle, D., Duda, J., Haman, L., Parizek, P., Coling, L., Neuzil, P., Petru, J., Sediva, L., Skoda, J., Chovancik, J., Fiala, M., Neuwirth, R., Karlsdottir, A., Pehrson, S., Gerdes, C., Jensen, H.K., Lukac, P., Nielsen, J. C., Hansen, J., Johannessen, A., Hansen, P. S., Pedersen, A.K., Heath, F.P., Hjortshoj, S., Thogersen, A.M., Da Costa, A., Martel, I., Romeyer-Bouchard, C., Sadki, N., Schmid, A., Haissaguerre, M., Hocini, M., Knecht, S., Sacher, F., Ait Said, M., Cauchemez, B., Ledoux, F., Thomas, O., Cebron, J.-P., Decarsin, N., Gras, D., Hervouet, S., Durand, C., Durand-Dubief, A., Poty, H., Babuty, D., Pierre, B., Albenque, J.-P., Boveda, S., Combes, N., Mas, R., Hermida, J-S., Kubala, M., Godin, B., Savouré, A., Soublin, Y., Defaye, P., Jacon, P., Brigadeau, F., Corbut, S., Flament-Balzola, F., Kacet, S., Klug, D., Lacroix, D., Copie, X., Gilles, L., Hocine, Z., Paziaud, O., Piot, O., Crocq, C., Kaballu, G., Le Moal, V., Lotton, P., Mabo, P., Pavin, D., Andronache, M., De Chillou, C., Magnin-Poull, I., Deharo, J.-C., Durand, C., Franceschi, F., Peyrouse, E., Prevot, S., Etchegoin, M., Extramiana, F., Leenhardt, A., Messali, A., Heine, T., Schneider, A., Winter, N., Brachmann, J., Ritscher, G., Schertel-Gruenler, B., Simon, H., Sinha, A.-M., Turschner, O., Wystrach, A., Stemberg, M., Kuck, K.-H., Metzner, A., Tilz, R., Wissner, E., Heitmann, K., Willems, S., Andresen, D., Mueller, S., Volkmer, M., Schmidt, B., Kostopoulou, A., Livanis, E., Voudris, V., Efremidis, M., Letsas, K., Tsikrikas, S., Christoforatou, E., Ioannidis, P., Katsivas, A., Kourouklis, S., Andrikopoulos, G., Rassias, I., Tzeis, S., Dakos, G., Paraskevaidis, S., Stavropoulos, G., Theofilogiannakos, E., Vassilikos, V.P., Bongiorni, M.G., Zucchelli, G., Raviele, A., Themistoclakis, S., Pratola, C., Tritto, M., Della Bella, P., Mazzone, P., Moltrasio, M., Tondo, C., Calo, L., De Luca, L., Guarracini, F., Lioy, E., Dozza, L., Frigoli, E., Giannelli, L., Pappone, C., Saviano, M., Schiavina, G., Vicedomini, G.G., De Ponti, R., Doni, L. A., Marazzi, R., Salerno-Uriarte, J.A., Tamborini, C., Anselmino, M., Ferraris, F., Gaita, F., Bertaglia, E., Brandolino, G., Zoppo, F., De Groot, N., Janse, P., Jordaens, L., Pison, L., Roos, C., Van Gelder, I., Manusama, R., Meijer, A., Van der Voort, P., Trines, S., Compier, Marieke G., Kazmierczak, J., Kornacewicz-Jach, Z., Wielusinski, M., Baran, J., Kulakowski, P., Dzidowski, M., Fuglewicz, A., Nowak, K., Pruszkowska-Skrzep, P., Wozniak, A., Nowak, S., Trusz-Gluza, M., Almendral, J., Atienza, F., Castellanos, E., De Diego, C., Ortiz, M., Moreno Planas, J., Perez Castellano, N., Benezet, J., Farre Muncharaz, J., Rubio Campal, J.M., Hernandez Madrid, A., Matia, R., Arana, E., Pedrote, A., Cozar, R., Peinado, R., Valverde, I., Arbelo, E., Berruezo, A., Calvo, N., Guiu, E., Husseini, S., and Mont Girbau, L.

Published
2014
Full Text
View/download PDF

20. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)

Author

Brugada, Josep, Katritsis, Demosthenes, Arbelo, Elena, Arribas, Fernando, Bax, Jeroen, Blomström-Lundqvist, Carina, Calkins, Hugh, Corrado, Domenico, Deftereos, Spyridon, Diller, Gerhard-Paul, Gomez-Doblas, Juan, Gorenek, Bulent, Grace, Andrew, Ho, Siew Yen, Kaski, Juan-Carlos, Kuck, Karl-Heinz, Lambiase, Pier David, Sacher, Frederic, Sarquella-Brugada, Georgia, Suwalski, Piotr, Zaza, Antonio, De Potter, Tom, Sticherling, Christian, Basso, Cristina, Bocchiardo, Mario, Budts, Werner, Dobrev, Dobromir, Gevaert, Sofie, Heidbuchel, Hein, Kanagaratnam, Prapa, Kriebel, Thomas, Lancellotti, Patrizio, Lopatin, Yury, Merkely, Béla, Paul, Thomas, Pavlović, Nikola, Potpara, Tatjana, Scherr, Daniel, Zeppenfeld, Katja, Windecker, Stephan, Aboyans, Victor, Baigent, Colin, Collet, Jean-Philippe, Dean, Veronica, Delgado, Victoria, Fitzsimons, Donna, Gale, Chris, Grobbee, Diederick, Halvorsen, Sigrun, Hindricks, Gerhard, Iung, Bernard, Jüni, Peter, Katus, Hugo, Landmesser, Ulf, Leclercq, Christophe, Lettino, Maddalena, Lewis, Basil, Merkely, Bela, Mueller, Christian, Petersen, Steffen, Petronio, Anna Sonia, Richter, Dimitrios, Roffi, Marco, Shlyakhto, Evgeny, Simpson, Iain, Sousa-Uva, Miguel, Touyz, Rhian, Amara, Walid, Grigoryan, Svetlana, Podczeck-Schweighofer, Andrea, Chasnoits, Alexandr, Vandekerckhove, Yves, Sokolovich, Sekib, Traykov, Vassil, Skoric, Bosko, Papasavvas, Elias, Kautzner, Josef, Riahi, Sam, Kampus, Priit, Parikka, Hannu, Piot, Olivier, Etsadashvili, Kakhaber, STELLBRINK, CHRISTOPH, Manolis, Antonis, Csanádi, Zoltán, Gudmundsson, Kristjan, Erwin, John, Barsheshet, Alon, De Ponti, Roberto, Abdrakhmanov, Ayan, Jashari, Haki, Lunegova, Olga, Jubele, Kristine, Refaat, Marwan, Puodziukynas, Aras, Groben, Laurent, Grosu, Aurel, Pavlovic, Nikola, Ibtissam, Fellat, Trines, Serge, Poposka, Lidija, Haugaa, Kristina, Kowalski, Oskar, Cavaco, Diogo, Dobreanu, Dan, Mikhaylov, Evgeny, Zavatta, Marco, Nebojša, Mujović, Hlivak, Peter, Ferreira-Gonzalez, Ignacio, Juhlin, Tord, Reichlin, Tobias, Haouala, Habib, Akgun, Taylan, Gupta, Dhiraj, IHU-LIRYC, and Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux]

Subjects
Tachycardia, pre-excitation, congenital, hereditary, and neonatal diseases and abnormalities, medicine.medical_specialty, focal, [SDV]Life Sciences [q-bio], Cardiology, Guidelines, 030204 cardiovascular system & hematology, tachycardia, arrhythmia, ablation, atrioventricular, flutter, junctional, macro–re-entrant, nodal, re-entrant, supraventricular, Electrocardiography, 03 medical and health sciences, 0302 clinical medicine, Tachycardia, Supraventricular, medicine, Humans, cardiovascular diseases, ComputingMilieux_MISCELLANEOUS, reproductive and urinary physiology, Task force, business.industry, Arrhythmias, Cardiac, 030229 sport sciences, medicine.disease, 3. Good health, EBSTEIN ANOMALY, embryonic structures, Emergency medicine, Catheter Ablation, cardiovascular system, Re entrant, Supraventricular tachycardia, medicine.symptom, Cardiology and Cardiovascular Medicine, business
Abstract

2019 ESC Guidelines for the management of patients with supraventricular tachycardia : The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC)

Published
2019
Full Text
View/download PDF

22. Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation.

Author

Endt, Vera H W van der, Milders, Jet, Vries, Bas B L Penning de, Trines, Serge A, Groenwold, Rolf H H, Dekkers, Olaf M, Trevisan, Marco, Carrero, Juan J, Diepen, Merel van, Dekker, Friedo W, Jong, Ype de, van der Endt, Vera H W, Penning de Vries, Bas B L, van Diepen, Merel, and de Jong, Ype

Subjects
ATRIAL fibrillation diagnosis, STROKE diagnosis, RISK assessment, EVALUATION research, RESEARCH funding, META-analysis, FERRANS & Powers Quality of Life Index, RESEARCH, RESEARCH methodology, CEREBRAL ischemia, STROKE, COMPARATIVE studies, ARTHRITIS Impact Measurement Scales
Abstract

Aims: Multiple risk scores to predict ischaemic stroke (IS) in patients with atrial fibrillation (AF) have been developed. This study aims to systematically review these scores, their validations and updates, assess their methodological quality, and calculate pooled estimates of the predictive performance.Methods and Results: We searched PubMed and Web of Science for studies developing, validating, or updating risk scores for IS in AF patients. Methodological quality was assessed using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). To assess discrimination, pooled c-statistics were calculated using random-effects meta-analysis. We identified 19 scores, which were validated and updated once or more in 70 and 40 studies, respectively, including 329 validations and 76 updates-nearly all on the CHA2DS2-VASc and CHADS2. Pooled c-statistics were calculated among 6 267 728 patients and 359 373 events of IS. For the CHA2DS2-VASc and CHADS2, pooled c-statistics were 0.644 [95% confidence interval (CI) 0.635-0.653] and 0.658 (0.644-0.672), respectively. Better discriminatory abilities were found in the newer risk scores, with the modified-CHADS2 demonstrating the best discrimination [c-statistic 0.715 (0.674-0.754)]. Updates were found for the CHA2DS2-VASc and CHADS2 only, showing improved discrimination. Calibration was reasonable but available for only 17 studies. The PROBAST indicated a risk of methodological bias in all studies.Conclusion: Nineteen risk scores and 76 updates are available to predict IS in patients with AF. The guideline-endorsed CHA2DS2-VASc shows inferior discriminative abilities compared with newer scores. Additional external validations and data on calibration are required before considering the newer scores in clinical practice.Clinical Trial Registration: ID CRD4202161247 (PROSPERO). [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

23. Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation

Author

Nucifora, Gaetano, Schuijf, Joanne D., van Werkhoven, Jacob M., Trines, Serge A., Kajander, Sami, Tops, Laurens F., Turta, Olli, Jukema, J. Wouter, Schreur, Joop H. M., Heijenbrok, Mark W., Gaemperli, Oliver, Kaufmann, Philipp A., Knuuti, Juhani, van der Wall, Ernst E., Schalij, Martin J., and Bax, Jeroen J.

Published
2011
Full Text
View/download PDF

26. Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation

Author

HAG Trombose, Team Medisch, Circulatory Health, JC onderzoeksprogramma Cardiovascular Health, HAG Hart- Vaatziekten, Chu, Gordon, Seelig, Jaap, Trinks-Roerdink, Emmy M., van Alem, Anouk P., Alings, Marco, van den Bemt, Bart, Boersma, Lucas Va, Brouwer, Marc A., Cannegieter, Suzanne C., Ten Cate, Hugo, Kirchhof, Charles Jhj, Crijns, Harry Jgm, van Dijk, Ewoud J., Elvan, Arif, van Gelder, Isabelle C., de Groot, Joris R., den Hartog, Frank R., de Jong, Jonas Ssg, de Jong, Sylvie, Klok, Frederikus A., Lenderink, Timo, Luermans, Justin G., Meeder, Joan G., Pisters, Ron, Polak, Peter, Rienstra, Michiel, Smeets, Frans, Tahapary, Giovanni Jm, Theunissen, Luc, Tieleman, Robert G., Trines, Serge A., van der Voort, Pepijn, Geersing, Geert Jan, Rutten, Frans H., Hemels, Martin Ew, Huisman, Menno V., HAG Trombose, Team Medisch, Circulatory Health, JC onderzoeksprogramma Cardiovascular Health, HAG Hart- Vaatziekten, Chu, Gordon, Seelig, Jaap, Trinks-Roerdink, Emmy M., van Alem, Anouk P., Alings, Marco, van den Bemt, Bart, Boersma, Lucas Va, Brouwer, Marc A., Cannegieter, Suzanne C., Ten Cate, Hugo, Kirchhof, Charles Jhj, Crijns, Harry Jgm, van Dijk, Ewoud J., Elvan, Arif, van Gelder, Isabelle C., de Groot, Joris R., den Hartog, Frank R., de Jong, Jonas Ssg, de Jong, Sylvie, Klok, Frederikus A., Lenderink, Timo, Luermans, Justin G., Meeder, Joan G., Pisters, Ron, Polak, Peter, Rienstra, Michiel, Smeets, Frans, Tahapary, Giovanni Jm, Theunissen, Luc, Tieleman, Robert G., Trines, Serge A., van der Voort, Pepijn, Geersing, Geert Jan, Rutten, Frans H., Hemels, Martin Ew, and Huisman, Menno V.

Published
2020

30. ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association

Author

Arbelo, Elena, Brugada, Josep, Hindricks, Gerhard, Maggioni, Aldo, Tavazzi, Luigi, Vardas, Panos, Anselme, Frédéric, Inama, Giuseppe, Jais, Pierre, Kalarus, Zbigniew, Kautzner, Josef, Lewalter, Thorsten, Mairesse, Georges, Perez-Villacastin, Julian, Riahi, Sam, Taborsky, Milos, Theodorakis, George, and Trines, Serge

Published
2012
Full Text
View/download PDF

37. Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation

Author

Chu, Gordon, primary, Seelig, Jaap, additional, Trinks-Roerdink, Emmy M, additional, van Alem, Anouk P, additional, Alings, Marco, additional, van den Bemt, Bart, additional, Boersma, Lucas VA, additional, Brouwer, Marc A, additional, Cannegieter, Suzanne C, additional, ten Cate, Hugo, additional, Kirchhof, Charles JHJ, additional, Crijns, Harry JGM, additional, van Dijk, Ewoud J, additional, Elvan, Arif, additional, van Gelder, Isabelle C, additional, de Groot, Joris R, additional, den Hartog, Frank R, additional, de Jong, Jonas SSG, additional, de Jong, Sylvie, additional, Klok, Frederikus A, additional, Lenderink, Timo, additional, Luermans, Justin G, additional, Meeder, Joan G, additional, Pisters, Ron, additional, Polak, Peter, additional, Rienstra, Michiel, additional, Smeets, Frans, additional, Tahapary, Giovanni JM, additional, Theunissen, Luc, additional, Tieleman, Robert G, additional, Trines, Serge A, additional, van der Voort, Pepijn, additional, Geersing, Geert-Jan, additional, Rutten, Frans H, additional, Hemels, Martin EW, additional, and Huisman, Menno V, additional

Published
2020
Full Text
View/download PDF

40. Influence of risk factors in the ESC-EHRA EORP atrial fibrillation ablation long-term registry

Author

Trines, Serge A., Stabile, Giuseppe, Arbelo, Elena, Dagres, Nikolaos, Brugada, Josep, Kautzner, Josef, Pokushalov, Evgeny, Maggioni, Aldo P., Laroche, Cecile, Anselmino, Matteo, Beinart, Roy, Traykov, Vassil, Blomström-Lundqvist, Carina, Trines, Serge A., Stabile, Giuseppe, Arbelo, Elena, Dagres, Nikolaos, Brugada, Josep, Kautzner, Josef, Pokushalov, Evgeny, Maggioni, Aldo P., Laroche, Cecile, Anselmino, Matteo, Beinart, Roy, Traykov, Vassil, and Blomström-Lundqvist, Carina

Abstract

Background: The influence of risk factors on atrial fibrillation (AF) ablation recurrence is increasingly recognized. We present a sub-analysis of the European Society of Cardiology-European Heart Rhythm Association-European Society of Cardiology AF ablation long-term registry on the effect of traditional risk factors for AF on postablation recurrence, reablation, and complications using real-world data. Methods: Risk factors for AF were defined as body mass index >= 27 kg/m(2), hypertension, chronic obstructive pulmonary disease, diabetes, alcohol >= 2 units/day, sleep apnea, smoking, no/occasional sports activity, moderate/severe mitral or aortic valve disease, any cardiomyopathy, peripheral vascular disease, chronic kidney disease, heart failure, coronary artery disease/infarction, and previous pacemaker/defibrillator implant. Patients were divided in two groups with >= 1 or without risk factors. Primary outcomes were arrhythmia recurrence after blanking period, reablation, and adverse events or death. Differences between the groups and the influence of individual risk factors were analyzed using multivariate Cox regression. Results: Three thousand sixty nine patients were included; 217 patients were without risk factors. Risk factor patients were older (58.4 vs 54.1 years), more often female (32% vs 19.8%) and had more often persistent AF (27.2% vs 23.5%). In a multivariate analysis, patients without risk factors had a hazard ratio of 0.70 (95% CI 0.49-0.99) for recurrence compared to risk factor patients. The multivariate hazard ratios for reablation or adverse events/death were not different between the two groups. Hypertension and body mass index were univariate predictors of recurrence. Conclusions: Patients with >= 1 risk factor had a 30% higher risk for arrhythmia recurrence after ablation, but no differences in risk for repeat ablations and adverse events or death.

Published
2019
Full Text
View/download PDF

42. Cryoballoon vs. radiofrequency ablation for atrial fibrillation : a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish catheter ablation registry.

Author

Mörtsell, David, Arbelo, Elena, Dagres, Nikolaos, Brugada, Josep, Laroche, Cécile, Trines, Serge A, Malmborg, Helena, Höglund, Niklas, Tavazzi, Luigi, Pokushalov, Evgeny, Stabile, Giuseppe, Blomström-Lundqvist, Carina, Mörtsell, David, Arbelo, Elena, Dagres, Nikolaos, Brugada, Josep, Laroche, Cécile, Trines, Serge A, Malmborg, Helena, Höglund, Niklas, Tavazzi, Luigi, Pokushalov, Evgeny, Stabile, Giuseppe, and Blomström-Lundqvist, Carina

Abstract

Aims: Pulmonary vein isolation (PVI), the standard for atrial fibrillation (AF) ablation, is most commonly applied with radiofrequency (RF) energy, although cryoballoon technology (CRYO) has gained widespread use. The aim was to compare the second-generation cryoballoon and the irrigated RF energy regarding outcomes and safety. Methods and results: Of 4657 patients undergoing their first AF ablation, 982 with CRYO and 3675 with RF energy were included from the Swedish catheter ablation registry and the Atrial Fibrillation Ablation Long-Term registry of the European Heart Rhythm Association of the European Society of Cardiology. The primary endpoint was repeat AF ablation. The major secondary endpoints included procedural duration, tachyarrhythmia recurrence, and complication rate. The re-ablation rate after 12 months was significantly lower in the CRYO vs. the RF group, 7.8% vs. 11%, P = 0.005, while freedom from arrhythmia recurrence (30 s duration) did not differ between the groups, 70.2 % vs. 68.2%, P = 0.44. The result was not influenced by AF type and lesion sets applied. In the Cox regression analysis, paroxysmal AF had significantly lower risk for re-ablation with CRYO, hazard ratio 0.56 (P = 0.041). Procedural duration was significantly shorter with CRYO than RF, (mean ± SD) 133.6 ± 45.2 min vs. 174.6 ± 58.2 min, P < 0.001. Complication rates were similar; 53/982 (5.4%) vs. 191/3675 (5.2%), CRYO vs. RF, P = 0.806. Conclusion: The lower re-ablation rates and shorter procedure times observed with the cryoballoon as compared to RF ablation may have important clinical implications when choosing AF ablation technique despite recognized limitations with registries.

Published
2019
Full Text
View/download PDF

43. Atrial fibrillation history impact on catheter ablation outcome : Findings from the ESC-EHRA atrial fibrillation ablation long-term registry

Author

Stabile, Giuseppe, Trines, Serge A, Arbelo, Elena, Dagres, Nikolaos, Brugada, Josep, Kautzner, Josef, Pokushalov, Evgeny, Maggioni, Aldo P, Laroche, Cecile, Anselmino, Matteo, Beinart, Roy, Traykov, Vassil, Blomström-Lundqvist, Carina, Stabile, Giuseppe, Trines, Serge A, Arbelo, Elena, Dagres, Nikolaos, Brugada, Josep, Kautzner, Josef, Pokushalov, Evgeny, Maggioni, Aldo P, Laroche, Cecile, Anselmino, Matteo, Beinart, Roy, Traykov, Vassil, and Blomström-Lundqvist, Carina

Abstract

BACKGROUND: Atrial fibrillation (AF) promotes atrial remodeling that in turn promote AF perpetuation. The aim of our study was to investigate the impact of AF history length on one-year outcome of AF catheter ablation in a cohort of patients enrolled in the Atrial Fibrillation Ablation Registry. METHODS: We described the real-life clinical epidemiology, therapeutic strategies and the short- and mid-term outcomes of 1948 patients (71.9% with paroxysmal AF) undergoing AF ablation procedures, stratified according to AF history duration (< 2 years or ≥ 2 years). RESULTS: The mean AF history duration was 46,2±57,4 months, 592 patients had an AF history duration < 2 years (mean 10,2±5,9 months), and 1356 patients ≥ 2 years (mean 75,5±63,5 months) (P < 0.001). Patients with AF history duration < 2 years were younger, had a lower incidence of hypertension, coronary artery disease, hypertrophic cardiomyopathy and had a lower CHA2 DS2 -VaSc Score. At one year, the logrank test showed a lower incidence of AF recurrence in patients with AF history duration < 2 years (28.9%) than in patients with AF history duration ≥ 2 years (34.0%) (P = 0.037). AF history duration ≥ 2 years, overall ablation procedure duration, hypertension and chronic kidney disease were all predictors of recurrences after the blanking period. CONCLUSIONS: In this multicenter registry, performing catheter ablation in patients with an AF history ≥ 2 years was associated with higher rates of AF recurrences at one year. Since cumulative time in AF in not necessarily equivalent to AF history, its role remains to be clarified.

Published
2019
Full Text
View/download PDF

44. Myocardial calcification is associated with endocardial ablation failure of post-myocardial infarction ventricular tachycardia.

Author

Riva, Marta de, Naruse, Yoshihisa, Ebert, Micaela, Watanabe, Masaya, Scholte, Arthur J, Wijnmaalen, Adrianus P, Trines, Serge A, Schalij, Martin J, Montero-Cabezas, Jose M, Zeppenfeld, Katja, and de Riva, Marta

Subjects
MYOCARDIAL infarction complications, CATHETER ablation, MYOCARDIAL infarction, RETROSPECTIVE studies, VENTRICULAR tachycardia, DISEASE relapse, TREATMENT effectiveness, ENDOCARDIUM
Abstract

Aims: In patients with post-myocardial infarction (post-MI) ventricular tachycardia (VT), the presence of myocardial calcification (MC) may prevent heating of a subepicardial VT substrate contributing to endocardial ablation failure. The aims of this study were to assess the prevalence of MC in patients with post-MI VT and evaluate the impact of MC on outcome after endocardial ablation.Methods and Results: In 158 patients, the presence of MC was retrospectively assessed on fluoroscopy recordings in seven standard projections obtained during pre-procedural coronary angiograms. Myocardial calcification, defined as a distinct radiopaque area that moved synchronously with the cardiac contraction, was detected in 30 patients (19%). After endocardial ablation, only 6 patients (20%) with MC were rendered non-inducible compared with 56 (44%) without MC (P = 0.033) and of importance, 8 (27%) remained inducible for the clinical VT [compared with 9 (6%) patients without MC; P = 0.003] requiring therapy escalation. After a median follow-up of 31 months, 61 patients (39%) had VT recurrence and 47 (30%) died. Patients with MC had a lower survival free from the composite endpoint of VT recurrence or therapy escalation at 24-month follow-up (26% vs. 59%; P = 0.003). Presence of MC (HR 1.69; P = 0.046), a lower LV ejection fraction (HR 1.03 per 1% decrease; P = 0.017), and non-complete procedural success (HR 2.42; P = 0.002) were independently associated with a higher incidence of VT recurrence or therapy escalation.Conclusion: Myocardial calcification was present in 19% of post-MI patients referred for VT ablation and was associated with a high incidence of endocardial ablation failure. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

45. Use of Smart Technology for the Early Diagnosis of Complications After Cardiac Surgery: The Box 2.0 Study Protocol (Preprint)

Author

Biersteker, Tom E, primary, Boogers, Mark J, additional, de Lind van Wijngaarden, Robert AF, additional, Groenwold, Rolf HH, additional, Trines, Serge A, additional, van Alem, Anouk P, additional, Kirchhof, Charles JHJ, additional, van Hof, Nicolette, additional, Klautz, Robert JM, additional, Schalij, Martin J, additional, and Treskes, Roderick W, additional

Published
2019
Full Text
View/download PDF

49. Cryoballoon versus radiofrequency ablation for atrial fibrillation – a study of outcome and safety based on the ESC-EHRA atrial fibrillation ablation long-term registry and the Swedish Catheter ablation registry

Author

Mörtsell, David, Arbelo, Elena, Dagres, Nikolaos, Brugada, Josep, Laroche, Cecile, Trines, Serge A, Malmborg, Helena, Höglund, Niklas, Tavazzi, Luigi, Pokushalov, Evgeny, Stabile, Guiseppe, Blomström-Lundqvist, Carina, Mörtsell, David, Arbelo, Elena, Dagres, Nikolaos, Brugada, Josep, Laroche, Cecile, Trines, Serge A, Malmborg, Helena, Höglund, Niklas, Tavazzi, Luigi, Pokushalov, Evgeny, Stabile, Guiseppe, and Blomström-Lundqvist, Carina

Abstract

Aims Pulmonary vein isolation (PVI), the standard for atrial fibrillation (AF) ablation, is most commonly applied with radiofrequency (RF) energy, although cryoballoon technology (CRYO) has gained widespread use. The aim was to compare the second generation cryoballoon and the irrigated RF energy regarding outcomes and safety. Methods Of 4657 patients undergoing their first AF ablation, 982 with CRYO and 3675 with RF energy were included from the Swedish catheter ablation registry and the Atrial Fibrillation Ablation Long-Term registry of the European Heart Rhythm Association of the European Society of Cardiology. The primary endpoint was repeat AF ablation. The major secondary endpoints included procedural duration, tachyarrhythmia recurrence and complication rate. Results The re-ablation rate after 12 months was significantly lower in the CRYO versus the RF group, 7.8% versus 11%, p=0.005, while freedom from arrhythmia recurrence (30 seconds duration) did not differ between the groups, 70.2 % versus 68.2%, p=0.44. The result was not influenced by AF type and lesion sets applied. In Cox regression analysis for re-ablation paroxysmal AF had significantly lower risk with CRYO, hazard ratio 0.56 (p=0.041). Procedural duration was significantly shorter with CRYO than RF, (mean±SD) 133.6±45.2 minutes versus 174.6±58.2 minutes, p<0.001. Complication rates were similar; 53/982 (5.4%) versus 191/3675 (5.2%), CRYO versus RF, p=0.806. Conclusion The lower re-ablation rates and shorter procedure times observed with the cryoballoon compares favorably with RF ablation. Although there are inherent limitations with registries, our findings may have important clinical implications when choosing AF ablation technique.

Published
2018

50. Additional file 2: of Mobile phones in cryptogenic strOke patients Bringing sIngle Lead ECGs for Atrial Fibrillation detection (MOBILE-AF): study protocol for a randomised controlled trial

Author

Treskes, Roderick, Gielen, Willem, Wermer, Marieke, Grauss, Robert, Alem, Anouk Van, Dehnavi, Reza, Kirchhof, Charles, Velde, Enno Van Der, Maan, Arie, Wolterbeek, Ron, Overbeek, Onno, Schalij, Martin, and Trines, Serge

Abstract

SPIRIT 2013 Checklist: recommended items to address in a clinical trial protocol and related documents*. (DOC 121 kb)

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results